We are monitoring the impact of COVID-19 & Recession alarm on North America Therapeutic Vaccines Market Get in touch with us for detailed analysis Know More
Share on

North America Therapeutic Vaccines Market Research Report – Segmented By Disease Type and Country (the United States, Canada and Rest of the North America) - Size, Share, Growth, Trends, And Forecasts (2022 to 2027)

Published: January, 2022
ID: 56
Pages: 140

North America Therapeutic Vaccines Market Size (2022 to 2027)

The North America Therapeutic Vaccines Market is set to reach USD 4362.14 Million by 2027 from USD 1140.67 Million in 2022, with a CAGR of 30.77% during the forecast period.

North America region is estimated to dominate the global temperature management market from 2020 to 2025 and even accounted for the largest market share in 2019. The market growth in this region is majorly supported by factors such as an increase in the volume of surgical procedures, growing elder people population, increasing the occurrence rate of cardiac arrest, and nerve disorders. Moreover, advanced technological products like battery-powered devices and standalone, which bolster the temperature management market in this region. U.S and Canada are the two major contributors to this region.

The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features that increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from the government for vaccine development, rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies and high costs associated with treatment are few factors inhibiting the market's growth.

This research report on the North America Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type:

  • Autoimmune Disease
  • Cancer
  • Neurological Disease
  • Infectious Disease

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, the United States therapeutic vaccines market is anticipated to register the highest market share in the North American market during the forecast period. There is a high demand for cosmetic surgeries in the United States coupled with the acquisitions of technologically advanced patient warming and cooling systems, rising number of government funds in improving healthcare infrastructure are significantly boosting the market in the United States.

The Canadian therapeutic vaccines market is expected to witness a healthy CAGR during the forecast period. Favorable reimbursement policies, the existence of major key players, a frequent increase of chronic diseases, and low-cost surgeries are accelerating Canada's growth during the analysis period.

Some of the prominent companies leading the North America Therapeutic Vaccines Market Profiled in the Report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                           

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                      

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 By Disease Type                                       

                                5.1.1 Autoimmune Disease Vaccines                      

                                5.1.2 Cancer Vaccines                    

                                                5.1.2.1 Multikine             

                                                5.1.2.2 PR1 Peptide        

                                                5.1.2.3 TroVax  

                                                5.1.2.4 CYT004-MelQbG10           

                                5.1.3 Neurological Disease Vaccines                        

                                                5.1.3.1 ACC- 001               

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Disease Vaccine        

                                                5.1.3.4 Alzheimer's Disease        

                                5.1.4 Infectious Disease Vaccines                             

                                                5.1.4.1 Hepatitis C           

                                                5.1.4.2 HIV/AIDS              

                                                5.1.4.3 Other Infectious Disease               

  1. Geographical Analysis

                6.1 Introduction                                               

                6.2 United States                                            

                6.3 Canada                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                              

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck and Company                                              

                8.3 Bavarian Nordic                                        

                8.4 CSL Limited                                 

                8.5 Emergent Biosolutions Inc.                                  

                8.6 Novartis AG                                

                8.7 Johnson and Johnson                                            

                8.8 MedImmune LLC                                     

                8.9 Pfizer Inc.                                    

                8.10 Sanofi Pasteur                                        

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                           

  1. List of Tables
  2. List of Figures
  1. North America Therapeutic Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  2. North America Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Billion)
  3. North America Autoimmune Disease Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Cancer Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Neurological Disease Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America Infectious Disease Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  8. North America Multikine Market, By Region, From 2022 - 2027 (USD Billion)
  9. North America PR1 Peptide Market, By Region, From 2022 - 2027 (USD Billion)
  10. North America TroVax Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America CYT004-MelQbG10 Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  13. North America ACC- 001 Market, By Region, From 2022 - 2027 (USD Billion)
  14. North America CAD 106 Market, By Region, From 2022 - 2027 (USD Billion)
  15. North America Parkinson's Vaccine Market, By Region, From 2022 - 2027 (USD Billion)
  16. North America Alzheimer's Vaccine Market, By Region, From 2022 - 2027 (USD Billion)
  17. North America Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  18. North America Hepatitis C Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  19. North America HIV/AIDS Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  20. North America Other Infectious Disease Vaccines Market, By Region, From 2022 - 2027 (USD Billion)
  21. United States Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Billion)
  22. Canada Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Billion)
  23. United States Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  24. Canada Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  25. United States Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  26. Canada Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  27. United States Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)
  28. Canada Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Billion)

 

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample